Spiritual Guidance That Propels Us Forward The Audacity of Faithful Leadership Sacred Teaching for Earthly Living Divine Council for the Multitude of People Celebrating God's Man for His People Celebrating God's Woman for His People Shaping Lives to be Good Stewards God's Chosen Vessel for His Purpose and Direction A Spiritual Briefing for the bodies of God The Gift of Giving For No Recompense Appreciating the Giver of Spiritual Knowledge Illustrating Holy Living Through Precept and Example Celebrating Victory in God's Holy Word Great Is Thy Faithfulness
Humira became the first and only FDA-approved non-steroid treatment for noninfectious uveitis in June 2016. This is an important advance in the treatment of noninfectious uveitis because long-term steroid use often leads to cataracts and glaucoma in uveitis patients. Because Humira doesn’t have the same side effects as steroids, it can be safely used to control the chronic inflammation associated with uveitis.
“The goal of the clinical trial was to determine whether Humira is a safe and effective alternative that could replace or minimize the use of steroids,” Dr. Jaffe said. “There are pros and cons to all of the treatments that we use, so we always need to reach a balance. And because uveitis is not just one, but rather a group of several different diseases, treatment must be highly individualized—not only by disease type and severity, but also with regard to the patient’s other health factors.”